Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal

The diagnosis of leprosy continues to be based on clinical symptoms and early diagnosis and treatment are critical to preventing disability and transmission. Sensitive and specific laboratory tests are not available for diagnosing leprosy. Despite the limited applicability of anti-phenolic glycolipid-I (PGL-I) serology for diagnosis, it has been suggested as an additional tool to classify leprosy patients (LPs) for treatment purposes. Two formats of rapid tests to detect anti-PGL-I antibodies [ML immunochromatography assay (ICA) and ML Flow] were compared in different groups, multibacillary patients, paucibacillary patients, household contacts and healthy controls in Brazil and Nepal. High ML Flow intra-test concordance was observed and low to moderate agreement between the results of ML ICA and ML Flow tests on the serum of LPs was observed. LPs were "seroclassified" according to the results of these tests and the seroclassification was compared to other currently used classification systems: the World Health Organization operational classification, the bacilloscopic index and the Ridley-Jopling classification. When analysing the usefulness of these tests in the operational classification of PB and MB leprosy for treatment and follow-up purposes, the ML Flow test was the best point-of-care test for subjects in Nepal and despite the need for sample dilution, the ML ICA test yielded better performance among Brazilian subjects. Our results identified possible ways to improve the performance of both tests.

Saved in:
Bibliographic Details
Main Authors: Stefani,Mariane Martins de Araújo, Grassi,Adriano Badotti, Sampaio,Lucas Henrique, Sousa,Ana Lúcia Osório Maroclo de, Costa,Maurício Barcelos, Scheelbeek,Pauline, Neupane,Kapil D, Hagge,Deanna A, Macdonald,Murdo, Cho,Sang-Nae, Oskam,Linda, Bührer-Sékula,Samira
Format: Digital revista
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2012
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000900019
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0074-02762012000900019
record_format ojs
spelling oai:scielo:S0074-027620120009000192013-01-02Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and NepalStefani,Mariane Martins de AraújoGrassi,Adriano BadottiSampaio,Lucas HenriqueSousa,Ana Lúcia Osório Maroclo deCosta,Maurício BarcelosScheelbeek,PaulineNeupane,Kapil DHagge,Deanna AMacdonald,MurdoCho,Sang-NaeOskam,LindaBührer-Sékula,Samira leprosy serologic tests immunochromatography The diagnosis of leprosy continues to be based on clinical symptoms and early diagnosis and treatment are critical to preventing disability and transmission. Sensitive and specific laboratory tests are not available for diagnosing leprosy. Despite the limited applicability of anti-phenolic glycolipid-I (PGL-I) serology for diagnosis, it has been suggested as an additional tool to classify leprosy patients (LPs) for treatment purposes. Two formats of rapid tests to detect anti-PGL-I antibodies [ML immunochromatography assay (ICA) and ML Flow] were compared in different groups, multibacillary patients, paucibacillary patients, household contacts and healthy controls in Brazil and Nepal. High ML Flow intra-test concordance was observed and low to moderate agreement between the results of ML ICA and ML Flow tests on the serum of LPs was observed. LPs were "seroclassified" according to the results of these tests and the seroclassification was compared to other currently used classification systems: the World Health Organization operational classification, the bacilloscopic index and the Ridley-Jopling classification. When analysing the usefulness of these tests in the operational classification of PB and MB leprosy for treatment and follow-up purposes, the ML Flow test was the best point-of-care test for subjects in Nepal and despite the need for sample dilution, the ML ICA test yielded better performance among Brazilian subjects. Our results identified possible ways to improve the performance of both tests.info:eu-repo/semantics/openAccessInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz v.107 suppl.1 20122012-12-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000900019en10.1590/S0074-02762012000900019
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Stefani,Mariane Martins de Araújo
Grassi,Adriano Badotti
Sampaio,Lucas Henrique
Sousa,Ana Lúcia Osório Maroclo de
Costa,Maurício Barcelos
Scheelbeek,Pauline
Neupane,Kapil D
Hagge,Deanna A
Macdonald,Murdo
Cho,Sang-Nae
Oskam,Linda
Bührer-Sékula,Samira
spellingShingle Stefani,Mariane Martins de Araújo
Grassi,Adriano Badotti
Sampaio,Lucas Henrique
Sousa,Ana Lúcia Osório Maroclo de
Costa,Maurício Barcelos
Scheelbeek,Pauline
Neupane,Kapil D
Hagge,Deanna A
Macdonald,Murdo
Cho,Sang-Nae
Oskam,Linda
Bührer-Sékula,Samira
Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal
author_facet Stefani,Mariane Martins de Araújo
Grassi,Adriano Badotti
Sampaio,Lucas Henrique
Sousa,Ana Lúcia Osório Maroclo de
Costa,Maurício Barcelos
Scheelbeek,Pauline
Neupane,Kapil D
Hagge,Deanna A
Macdonald,Murdo
Cho,Sang-Nae
Oskam,Linda
Bührer-Sékula,Samira
author_sort Stefani,Mariane Martins de Araújo
title Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal
title_short Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal
title_full Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal
title_fullStr Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal
title_full_unstemmed Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal
title_sort comparison of two rapid tests for anti-phenolic glycolipid-i serology in brazil and nepal
description The diagnosis of leprosy continues to be based on clinical symptoms and early diagnosis and treatment are critical to preventing disability and transmission. Sensitive and specific laboratory tests are not available for diagnosing leprosy. Despite the limited applicability of anti-phenolic glycolipid-I (PGL-I) serology for diagnosis, it has been suggested as an additional tool to classify leprosy patients (LPs) for treatment purposes. Two formats of rapid tests to detect anti-PGL-I antibodies [ML immunochromatography assay (ICA) and ML Flow] were compared in different groups, multibacillary patients, paucibacillary patients, household contacts and healthy controls in Brazil and Nepal. High ML Flow intra-test concordance was observed and low to moderate agreement between the results of ML ICA and ML Flow tests on the serum of LPs was observed. LPs were "seroclassified" according to the results of these tests and the seroclassification was compared to other currently used classification systems: the World Health Organization operational classification, the bacilloscopic index and the Ridley-Jopling classification. When analysing the usefulness of these tests in the operational classification of PB and MB leprosy for treatment and follow-up purposes, the ML Flow test was the best point-of-care test for subjects in Nepal and despite the need for sample dilution, the ML ICA test yielded better performance among Brazilian subjects. Our results identified possible ways to improve the performance of both tests.
publisher Instituto Oswaldo Cruz, Ministério da Saúde
publishDate 2012
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762012000900019
work_keys_str_mv AT stefanimarianemartinsdearaujo comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
AT grassiadrianobadotti comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
AT sampaiolucashenrique comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
AT sousaanaluciaosoriomaroclode comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
AT costamauriciobarcelos comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
AT scheelbeekpauline comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
AT neupanekapild comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
AT haggedeannaa comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
AT macdonaldmurdo comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
AT chosangnae comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
AT oskamlinda comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
AT buhrersekulasamira comparisonoftworapidtestsforantiphenolicglycolipidiserologyinbrazilandnepal
_version_ 1756383738353156096